Literature DB >> 21403606

Epigenetic events in tumorigenesis: putting the pieces together.

I P Pogribny1.   

Abstract

The development of cancer is a complex multifactorial process traditionally viewed as the stepwise accumulation of genetic alterations. However, recent advances in field of cancer research have established that all major human cancers, in addition to a large number of genetic alterations, exhibit prominent epigenetic abnormalities. This review presents current evidence that epigenetic alterations are not only key features of cancer cells, but they also may be key events in the initiation of carcinogenesis. The early appearance of cancer-linked epigenetic changes that are similar to those found in malignant cells provides a unique opportunity to use them as biomarkers in early cancer detection, indicators of carcinogenic exposure, and in the assessment of the carcinogenic potential of environmental chemical and physical agents.

Entities:  

Mesh:

Year:  2010        PMID: 21403606

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  11 in total

Review 1.  The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling.

Authors:  Wilhelm Engström; Philippa Darbre; Staffan Eriksson; Linda Gulliver; Tove Hultman; Michalis V Karamouzis; James E Klaunig; Rekha Mehta; Kim Moorwood; Thomas Sanderson; Hideko Sone; Pankaj Vadgama; Gerard Wagemaker; Andrew Ward; Neetu Singh; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Anna Maria Colacci; Monica Vaccari; Chiara Mondello; A Ivana Scovassi; Jayadev Raju; Roslida A Hamid; Lorenzo Memeo; Stefano Forte; Rabindra Roy; Jordan Woodrick; Hosni K Salem; Elizabeth P Ryan; Dustin G Brown; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

2.  Identifying early events of gene expression in breast cancer with systems biology phylogenetics.

Authors:  M S Abu-Asab; N Abu-Asab; C A Loffredo; R Clarke; H Amri
Journal:  Cytogenet Genome Res       Date:  2013-04-03       Impact factor: 1.636

Review 3.  Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues.

Authors:  Eline M Bunnik; Maartje H N Schermer; A Cecile J W Janssens
Journal:  BMC Med Ethics       Date:  2011-06-14       Impact factor: 2.652

4.  From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms.

Authors:  Marion Martin; Zdenko Herceg
Journal:  Genome Med       Date:  2012-01-31       Impact factor: 11.117

Review 5.  Epigenetic modifications of caveolae associated proteins in health and disease.

Authors:  Jin-Yih Low; Helen D Nicholson
Journal:  BMC Genet       Date:  2015-06-26       Impact factor: 2.797

Review 6.  The Human Genome Project, and recent advances in personalized genomics.

Authors:  Brenda J Wilson; Stuart G Nicholls
Journal:  Risk Manag Healthc Policy       Date:  2015-02-16

7.  Epigenetics and the human brain: where nurture meets nature.

Authors:  Isabelle M Mansuy; Safa Mohanna
Journal:  Cerebrum       Date:  2011-05-25

8.  Epigenetic reprogramming in Mist1(-/-) mice predicts the molecular response to cerulein-induced pancreatitis.

Authors:  Rashid Mehmood; Gabor Varga; Sonali Q Mohanty; Scott W Laing; Yuefeng Lu; Charis L Johnson; Alexei Kharitonenkov; Christopher L Pin
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

Review 9.  Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-review.

Authors:  Maisa Mahmoud Ali Kamkar; Rasheed Ahmad; Osama Alsmadi; Kazem Behbehani
Journal:  J Diabetes Metab Disord       Date:  2014-05-22

10.  Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylation.

Authors:  Neng Wang; Zhiyu Wang; Yu Wang; Xiaoming Xie; Jiangang Shen; Cheng Peng; Jieshu You; Fu Peng; Hailin Tang; Xinyuan Guan; Jianping Chen
Journal:  Oncotarget       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.